Battery ‘bath’ restores spent lithium-ion cells to 95% power, cuts recycling costs 56%

Electrochemical bath recycles critical minerals in batteries
Credit: Shea Oleksa/Cornell University

The critical minerals that power lithium-ion batteries are in high demand and short supply, especially for the U.S., which must rely on importing resources such as nickel and cobalt to manufacture the technology.

Cornell researchers have now developed a more efficient and cost-effective way to recover almost the full life of these batteries after they are spent. By using an electrochemical solution to regenerate their electrodes, the recycled batteries can regain up to 95% of their original power and last longer when reused, the researchers demonstrated.

The process could also slash current recycling costs by 56% and would be more environmentally friendly than current methods.

The findings were published in Energy & Environmental Science...

Read More

Scientists think they solved the mystery of the Amaterasu particle

Partial image of Earth being struck by beam of light representing ultra-high energy cosmic ray from space, with galaxies and neutron stars in background.
Artist’s impression of an ultra-high energy cosmic ray reaching Earth. New research suggests that some of the highest-energy cosmic rays may consist of atomic nuclei heavier than iron. The background depicts candidate source objects for these cosmic rays, such as active galactic nuclei and strongly magnetized neutron stars. Credit: Osaka Metropolitan University/Kyoto University L-INSIGHT/Ryuunosuke Takeshige. All Rights Reserved.

The mysterious Amaterasu particle may not be a proton at all. New research suggests that some of the most extreme cosmic rays could be ultraheavy atomic nuclei, heavier than iron, which are better able to retain their energy while traveling through space...

Read More

AI-designed universal vaccine clears first human trial, targets future coronavirus threats with needle-free delivery

Illustration of a colorful virus particle breaking apart, representing an AI-designed universal vaccine targeting rapidly mutating virus variants.
(Image Credit: Corona Borealis Studio/Shutterstock)

The first human clinical trial of a universal Sarbeco coronavirus vaccine, developed by the University of Cambridge and spin-out DIOSynVax (DVX) Ltd, has shown that the vaccine is safe and has no significant side effects.

The trial, involving 39 healthy volunteers, tested a vaccine designed to provide protection against multiple Sarbeco coronaviruses—the large group of viruses that occur in nature including SARS-CoV-2, which caused the COVID pandemic.

The vaccine triggered immune responses in the volunteers not only to SARS-CoV-2 and SARS, but to related bat viruses that could potentially jump from animals to humans and cause future pandemics.

This trial proves the safety of an entirely new way of designing vaccines...

Read More

Driverless cars are on the rise and now we may know why they crash

Driverless car
Credit: Unsplash/CC0 Public Domain

For the first time, new algorithms may be able to automatically explain why some self-driving cars crash—a question crucial to answer as more autonomous vehicles take to the roads. This new approach, developed by researchers at King’s College London, reviews past events to explain why specific instances of failure happened, in the hope that this can be used to make improvements in the future.

The research was presented at the 2026 IEEE International Conference of Robotics and Automation.

Self-driving vehicles are increasingly being rolled out across the globe, in cities like London and San Francisco, but collisions and serious breaches of road safety have put pressure on manufacturers to explain why they make the mistakes they do...

Read More